Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 October 2023 | Story Carmenita Redcliffe-Paul

The University of the Free State (UFS) and the South African Chamber of Commerce United Kingdom (SACC UK) are pleased to invite you to the next conversation of the Global Citizen Series.

SACC UK representative, Director of Mindofafox, futurist, and bestselling author, Chantell Ilbury, will facilitate this thought-provoking and engaging conversation between UFS Vice-Chancellor and Principal, Prof Francis Petersen, and President and Chief Executive of the International Council on Mining and Metals (ICMM), Rohitesh Dhawan.

The discussion will explore the strategic priorities and breakthroughs in the mining and metals industry in relation to critical areas of climate and environmental resilience, social performance, governance, ethics and transparency, and innovation for sustainability. 

Dhawan, a Fellow and faculty member of the Africa Leadership Initiative, will reflect on leadership through collaboration to enhance the contribution of mining and metals towards sustainable development, security of minerals within a changing geopolitical environment and the progress that is possible when citizens collectively focus on improving the lives of others and our planet.

Participate in the Global Citizen event in person or online via live stream. 

Kindly RSVP on the links below and indicate your preferred method of participation.

Join the Global Citizen in person in London, United Kingdom

Date: Wednesday, 8 November 2023 
Time: 17:30-19:30
Venue: SOAS Brunei Gallery – SOAS, University of London, Thornhaugh Street, Russell Sq, London WC1B 5DQ, United Kingdom
RSVP: Friday, 27 October 2023 
Enquiries: Adrienne Hall E: adrienne@creative-partnerships.co.uk or T: +44 7469 219157

Light refreshments will be served after the event.

Join the Global Citizen event online

Date: Wednesday, 8 November 2023 
SA time 20:00-21:00 SAST
UK time 18:00-19:00 GMT
RSVP here by Friday, 3 November 2023 

The live stream link will be shared upon RSVP.

About Rohitesh Dhawan

Rohitesh Dhawan was appointed President and Chief Executive Officer of ICMM in April 2021. He is passionate about the transformative power of mining, particularly in emerging markets where he has spent two-thirds of his life. Dhawan is a Fellow and faculty member of the Africa Leadership Initiative and a Raisina fellow of the Asian Forum on Global Governance. He serves on the advisory boards of the Columbia Centre on Sustainable Investment, Concordia, and Resolve.  

Read more about Rohitesh Dhawan here.

News Archive

Chakalaka can have side effects for these patients
2010-06-24

Chakalaka is a sauce many South Africans cannot imagine a meal without, but research at the Faculty of Health Sciences at the University of the Free State (UFS) has shown that it can have serious side effects and even compromise the treatment of leukaemia patients.

Prof. Vernon Louw from the Department of Internal Medicine at the Faculty says that tyrosine kinase inhibitors (TKIs) are a new group of drugs providing targeted therapy for chronic myeloid leukaemia (CML). It vastly contributes to the survival of patients, but it has side effects like vasodilatation. Research has shown that spices like chakalaka may aggravate vasodilatation (widening of veins) with patients on these drugs.

“These spices produce serious oedema (water retention) and headaches. We have found that discontinuing the intake of spices allows some patients to maintain therapeutic doses of TKIs.” Chakalaka contains mainly garlic and chilli.

CML represents up to 20% of all leukaemia patients in South Africa and up to 450 new cases are reported every year.

In the study symptoms of severe headache and oedema disappeared within days of discontinuing the use of chakalaka.

Prof. Louw says it is important for oncologists to ask their patients about their intake of spices and garlic when they are on TKIs. It is also advisable to enquire about the use of complementary alternative medicine as the interaction of these medicines in cancer treatment is not known.

Media Release

Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
23 June 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept